Discouraging inappropriate antibiotic use will require changing how patients and physicians are reimbursed for antibiotic prescriptions, and how physicians are paid for prescribing them.
Antibiotic resistance stems from insufficient incentives for patients, physicians, hospitals, and drug companies to do the right thing.
Dates of Project: May 2005 to December 2011
Field of Work: Antibiotic resistance
Problem Synopsis: Modern medicine depends on antibiotics to control bacterial infections, but pathogens resistant to antibiotics have emerged and spread rapidly. The Institute of Medicine and many others have sounded urgent calls to address this growing threat, yet policy-makers have done little to respond.
Synopsis of the Work: Extending the Cure researchers evaluated antibiotics and resistance of them, and proposed incentives to make the best use of existing antibiotics and encourage the discovery of new ones. The researchers framed the problem as one of “the commons”: antibiotics are a shared resource like clean air and safe drinking water, and any use of these drugs diminishes their overall effectiveness.
Key Results: Extending the Cure researchers:
- Published Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance, which concludes that patients, physicians, hospitals, and drug companies have insufficient incentives to conserve the effectiveness of existing antibiotics. What is good for each patient and entity conflicts with what is good for society.
- Published 23 journal articles, and 13 policy briefs on antibiotic resistance and potential responses.
- Launched the Drug Resistance Index, which tracks the resistance of microbes that cause common diseases, based on their resistance to individual drugs and the frequency with which clinicians prescribe them.
- Developed the ResistanceMap, which shows changes in antibiotic use and the resistance of microbes to individual drugs across North America and Europe.
Related antibiotics create cross-resistance, so each drug company has little incentive to consider resistance if other firms are selling similar drugs.
#Superbugs. Public stewardship of antibiotics essential to wise use by docs, drug cos., and patients.
RWJF Scholar examines neighborhood-based death rates from opiate-based painkiller overdoses, compared with heroin overdose deaths.
A national conversation highlighting efforts to improve care transitions, reduce avoidable hospital readmissions, and lift overall quality o...
Adverse working conditions contribute substantially to the risk of depression for working-age adults, according to new research from a team ...
This month the Johns Hopkins Bloomberg School of Public Health published a special issue of its magazine devoted to food.
Unengaged patients can incur costs of up to 21% higher than patients who are highly engaged in care. This suite of materials from RWJF's AF4...
America is not getting good value for its health care dollar. These resources explore issues of cost and value of health care.
Hilary Levey Friedman, author of Playing to Win: Raising Children in a Competitive Culture, writes about youth sports.
RWJF Nurse Faculty Scholar Jennifer Bellot writes about losing her grandmother to complications from a medical error.
The reconvened Commission to Build a Healthier America will provide new guidance in three key areas: early childhood, healthy communities, a...
RWJF Scholar puzzles out why people who do not drink alcohol are at greater risk for premature death than light to moderate drinkers.
While the need to address disparities in care is well known, few strategies for reducing disparities have been studied systematically.
Judith Halstead, president of the National League for Nursing, writes about the role of nursing education in realizing a transformed health ...